Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Maechler

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Thrombosis and Haemostasis : JTH|July 15, 2006
Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptorsS Zarei, M Frieden, B Rubi, et al.
Diabetologia|November 13, 2009
Peroxisome proliferator-activated receptor alpha (PPARalpha) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolismF Frigerio, T Brun, C Bartley, et al.
The Journal of Biological Chemistry|April 20, 2001
Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiationH Wang, P Maechler, B Ritz-Laser, et al.
Diabetologia|June 1, 2006
Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell functionP B M de Andrade, B Rubi, F Frigerio, et al.
Diabetologia|April 4, 2008
Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cellsD Martin, F Allagnat, G Chaffard, et al.
Biochemical Pharmacology|February 9, 2010
The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cellsJ E de Leeuw van Weenen, E T Parlevliet, P Maechler, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 30, 2018
Chronic orexin-A (hypocretin-1) treatment of type 2 diabetic rats improves glucose control and beta-cell functionsP Kaczmarek, M Skrzypski, E Pruszynska-Oszmalek, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Thrombosis and Haemostasis : JTH|July 15, 2006
Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptorsS Zarei, M Frieden, B Rubi, et al.
Diabetologia|November 13, 2009
Peroxisome proliferator-activated receptor alpha (PPARalpha) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolismF Frigerio, T Brun, C Bartley, et al.
The Journal of Biological Chemistry|April 20, 2001
Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiationH Wang, P Maechler, B Ritz-Laser, et al.
Diabetologia|June 1, 2006
Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell functionP B M de Andrade, B Rubi, F Frigerio, et al.
Diabetologia|April 4, 2008
Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cellsD Martin, F Allagnat, G Chaffard, et al.
Biochemical Pharmacology|February 9, 2010
The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cellsJ E de Leeuw van Weenen, E T Parlevliet, P Maechler, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 30, 2018
Chronic orexin-A (hypocretin-1) treatment of type 2 diabetic rats improves glucose control and beta-cell functionsP Kaczmarek, M Skrzypski, E Pruszynska-Oszmalek, et al.
Pageof 4